Risk Factor for Poor Outcome in Elderly Patients with Aneurysmal Subarachnoid Hemorrhage Based on Post Hoc Analysis of the Modified WFNS Scale Study.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
09 2020
Historique:
received: 11 02 2020
revised: 20 05 2020
accepted: 21 05 2020
pubmed: 1 6 2020
medline: 1 1 2021
entrez: 1 6 2020
Statut: ppublish

Résumé

There is currently no precise guide for the treatment and management of elderly patients with aneurysmal subarachnoid hemorrhage (aSAH). Thus, the aim of this study was to clarify the factors of poor outcome and mortality in elderly patients with aSAH. In the modified World Federation of Neurosurgical Societies (mWFNS) scale study, 1124 patients were divided into 2 groups, elderly (age ≥65 years) and non-elderly (age <65 years), with aSAH investigated between October 2010 and March 2013 in Japan. The odds ratio (OR) and 95% confidence interval (CI) of each risk factor was calculated through multivariate logistic regression analysis for poor outcomes, as indicated by the modified Rankin Scale (mRS) score ≥3 and mortality at 3 months after onset in each group. Both groups demonstrated that the mWFNS scale was significant as a grade order risk factor for poor outcomes and mortality associated with disease. In the elderly group, risk factors for poor outcomes at 3 months after onset were older age (OR 1.10, 95% CI 1.06-1.14), male sex (OR 2.03, 95% CI 1.10-3.73), and severe cerebral vasospasm category (OR 10.13, 95% CI 4.30-23.87). Risk factors for mortality at 3 months after onset were older age (OR 1.06, 95% CI 1.01-1.11) and severe vasospasm category (OR 2.17, 95% CI 1.00-4.72). The mWFNS scale is a useful prognostic predictor for both non-elderly and elderly patients with aSAH. Elderly male patients with aSAH presenting with severe vasospasm should be managed more carefully.

Identifiants

pubmed: 32474089
pii: S1878-8750(20)31167-0
doi: 10.1016/j.wneu.2020.05.196
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e466-e473

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Iori Ozono (I)

Department of Neurosurgery, Shimane Prefectural Central Hospital, Izumo, Japan.

Fusao Ikawa (F)

Department of Neurosurgery, Shimane Prefectural Central Hospital, Izumo, Japan; Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Electronic address: fikawa-nsu@umin.ac.jp.

Toshikazu Hidaka (T)

Department of Neurosurgery, Shimane Prefectural Central Hospital, Izumo, Japan.

Michitsura Yoshiyama (M)

Department of Neurosurgery, Shimane Prefectural Central Hospital, Izumo, Japan.

Shingo Matsuda (S)

Department of Neurosurgery, Shimane Prefectural Central Hospital, Izumo, Japan.

Nobuaki Michihata (N)

Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.

Hitoshi Kobata (H)

Department of Neurosurgery, Osaka Mishima Emergency Critical Care Center, Osaka, Japan.

Yuichi Murayama (Y)

Department of Neurosurgery, The Jikei University School of Medicine, Tokyo, Japan.

Akira Sato (A)

Department of Emergency, Tokyo Kyosai Hospital, Tokyo, Japan.

Yoko Kato (Y)

Department of Neurosurgery, Fujita Health University Bantane Hospital, Nagoya, Japan.

Hirotoshi Sano (H)

Department of Neurosurgery, Shinkawabashi Hospital, Kawasaki, Japan.

Shuhei Yamaguchi (S)

Department of Neurology, Shimane Prefectural Central Hospital, Izumo, Japan.

Kaoru Kurisu (K)

Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH